应
应大为
Executive Director·OrbiMed
应大为, also listed by OrbiMed as Daniel Ying, is an Executive Director on OrbiMed's Asia team and joined the firm in 2018. Before OrbiMed, he worked as an Assistant Vice President at C-Bridge Capital focusing on pharmaceutical and biotechnology investments. He previously worked at IMS Consulting Group, now part of IQVIA, and received bachelor's and master's degrees in Chemistry from Tsinghua University.
See the rest of 应大为's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.